Hi colquhounFrom Thunder’s post # 4105590'Documentation to ASIC...

Hi colquhoun

From Thunder’s post # 4105590

'Documentation to ASIC shows that Biosignal was introduced to a US biopharmaceutical
company by Dr D’Sylva and that a merger as part of a broader $2 million capital raising to
be underwritten by Chimaera Capital would occur, along with the placement of 12,000,000
one cent shares to Chemventures, which would fund Biosignal to the proposed merger.
Along the way, Chemventures was replaced by Empire Investments'

So it seems that there was a plan for a $2m capital raising. A lot has changed since then but it could still happen.

BOS will be issuing an unstated number of our shares to CBTE for 0.030 each, but CBTE doesn’t have a lot of cash. Maybe their merger target GL Biochem Shanghai has a few spare dollars? Still at $0.030 how many would you want sold with the associated dilution? I rather thought straight cash would have been a better deal.

The 12 million shares could only be those given to Empire Investments for $12k. It may be stock standard, but I thought an escrow of only three months was a bit brief. I went back through the announcements but couldn’t find any mention of it.

Interesting days.